Search

everythinglearnresearchcommunity

for

Search:↓

All three treatments reduce hirsutism, but spironolactone works best long-term.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

Bismuth subgallate and borneol together improve skin wound healing better than when used separately or compared to other treatments.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Hormonal therapies are safe and effective for treating adult women's acne.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Minoxidil effectively treats female pattern hair loss.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.